About Stabilis Medical

Advancing the Science of
Human Stability.

Stabilis Medical is building a new generation of therapeutic technologies designed to improve movement, reduce tremors, and redefine everyday neurological care.

Why we exist

The problem we're solving is real. And it's largely ignored.

The future of movement disorder care cannot remain reactive, invasive, or confined to the clinic.

Fewer than 1 in 4 Parkinson's patients have access to consistent physical therapy, while existing treatment options often fail to adapt alongside disease progression and daily symptom fluctuation.

We believe therapeutic care should be continuous, connected, and integrated seamlessly into everyday life.

"We are building therapeutic technologies designed to improve movement, reduce tremors, and support quality of life through connected, physician guided care that works alongside existing treatments."

What we believe

—

Non-invasive. Worn on the body through fully wearable therapeutic technology designed without implanted devices or invasive procedures.

—

Non-pharmacological. Works alongside medication through therapeutic care designed to support movement and everyday quality of life.

—

Home-based. Therapy designed to be accessible from home through connected monitoring and physician guided care.

—

Physician-guided. Prescribed by your physician and monitored remotely through therapeutic care designed around your everyday life.

—

Scalable. A connected therapeutic platform designed to support care anytime, anywhere through continuous monitoring and adaptive technology.

The team

The people building it.

Stabilis Medical was founded by a team with deep experience in medical devices, neurology, AI-driven hardware, and patient-centered design.

Colleen McNutt

Colleen McNutt

CEO & Founder

Colleen founded Stabilis Medical after a personal health journey inspired a deep belief in the power of technology to transform patient care and quality of life. With a background in economics from Columbia University, she created the company to develop intelligent wearable therapeutics designed to restore function, improve independence, and reshape the future of neurological care.

Akhil Tripathi

Akhil Tripathi

Chief Medical Officer

University of Miami

Professor Tripathi brings deep clinical expertise in neurology and movement disorders. His academic affiliation with the University of Miami grounds Stabilis's clinical approach in rigorous medical research and gives the company direct access to patient populations and institutional knowledge.

Dominic Kuang

Dominic Kuang

Chief Technology Officer

Founder, 9Dot Labs

Dominic previously co-founded Damen, where he developed AI-controlled airbag systems for motorcyclists — building closed-loop safety technology that senses, decides, and responds in milliseconds. That same architecture — sensor fusion, closed-loop feedback, autonomous real-time response — is the technical foundation of both Stabilis devices.

Raymond Yeager

Raymond Yeager

Chief Financial Officer

Raymond brings over 25 years of senior financial leadership across global technology companies, having previously led international finance operations at Apple, Siemens, McGraw-Hill, and DST Systems. An ACA-qualified CFO with a long track record of driving growth and transformation, Raymond brings the financial rigor and strategic discipline to support Stabilis Medical's path to commercialization and scale.

Traction

Where we've been. Where we're going.

2024

Pilot Trial Completed

40+ Parkinson's patients. 12-week program. 3 sessions per week, 20 minutes each. High patient adherence and strong enthusiasm for continued therapeutic use. 4.8 out of 5 patient satisfaction score.

Oct 2024

Vision NextGen — 3rd Place

3rd place out of 200+ companies at the Global Health Exhibition in Riyadh, Saudi Arabia. One of 30 semi-finalists selected to present to a panel of investors, industry leaders, and government officials.

Apr 2025

Venture Summit West — Top Innovator

Selected as one of 150 top innovators to present at Venture Summit West at the Computer History Museum in Silicon Valley, organized by youngStartup Ventures.

2026

Active R&D — Tremor Detection Feasibility

In active collaboration with Simbex, a leading biomedical R&D firm, validating the core tremor detection architecture of our EEG + PAS wearable system. This feasibility phase focuses on EEG biomarker identification, electrode placement optimization, and closed-loop signal processing — advancing the system toward clinical validation.

Ongoing

Strategic Partnership

Pending Joint Development Collaboration

Advancing device development in strategic alignment with Cleveland Clinic, with a pending joint development agreement focused on supporting future clinical development of the NMES therapeutic suit and EEG + PAS wearable system.

2027 (Planned)

Multi-Site Clinical Trials

Planned multi-site clinical trials with the Cleveland Clinic, validating both the NMES therapeutic suit and the EEG + PAS wearable system across Parkinson's disease and essential tremor patient populations. These trials will generate the clinical evidence required to support FDA submission pathways for both devices.

Join the team

Build the Future of
Neurological Care.

We are bringing together innovators across neuroscience, engineering, AI, and medicine to build intelligent therapeutic technologies designed to improve millions of lives. If you are driven by innovation, purpose, and the opportunity to shape the future of medicine, we want to hear from you.

Neurotechnology · Patient Impact · Early Stage · Cleveland Clinic Partnership
Explore Opportunities